Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsFahrner, Jill A
Riddle, Ryan C
DeLeon, Valerie B
Lad, Susan E
Luperchio, Teresa Romeo
Hansen, Kasper D
Bjornsson, Hans T
MetadataShow full item record
CitationFahrner JA, Lin WY, Riddle RC, Boukas L, DeLeon VB, Chopra S, Lad SE, Luperchio TR, Hansen KD, Bjornsson HT. Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice. JCI Insight. 2019 Oct 17;4(20):e129380. doi: 10.1172/jci.insight.129380
AbstractKabuki syndrome 1 (KS1) is a Mendelian disorder of the epigenetic machinery caused by mutations in the gene encoding KMT2D, which methylates lysine 4 on histone H3 (H3K4). KS1 is characterized by intellectual disability, postnatal growth retardation, and distinct craniofacial dysmorphisms. A mouse model (Kmt2d+/βGeo) exhibits features of the human disorder and has provided insight into other phenotypes; however, the mechanistic basis of skeletal abnormalities and growth retardation remains elusive. Using high-resolution micro-CT, we show that Kmt2d+/βGeo mice have shortened long bones and ventral bowing of skulls. In vivo expansion of growth plates within skulls and long bones suggests disrupted endochondral ossification as a common disease mechanism. Stable chondrocyte cell lines harboring inactivating mutations in Kmt2d exhibit precocious differentiation, further supporting this mechanism. A known inducer of chondrogenesis, SOX9, and its targets show markedly increased expression in Kmt2d-/- chondrocytes. By transcriptome profiling, we identify Shox2 as a putative KMT2D target. We propose that decreased KMT2D-mediated H3K4me3 at Shox2 releases Sox9 inhibition and thereby leads to enhanced chondrogenesis, providing a potentially novel and plausible explanation for precocious chondrocyte differentiation. Our findings provide insight into the pathogenesis of growth retardation in KS1 and suggest therapeutic approaches for this and related disorders.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- Precocious neuronal differentiation and disrupted oxygen responses in Kabuki syndrome.
- Authors: Carosso GA, Boukas L, Augustin JJ, Nguyen HN, Winer BL, Cannon GH, Robertson JD, Zhang L, Hansen KD, Goff LA, Bjornsson HT
- Issue date: 2019 Oct 17
- The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology.
- Authors: Shpargel KB, Mangini CL, Xie G, Ge K, Magnuson T
- Issue date: 2020 Jul 17
- The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.
- Authors: Schwenty-Lara J, Nehl D, Borchers A
- Issue date: 2020 Jan 15
- Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome.
- Authors: Pilarowski GO, Cazares T, Zhang L, Benjamin JS, Liu K, Jagannathan S, Mousa N, Kasten J, Barski A, Lindsley AW, Bjornsson HT
- Issue date: 2020 Mar
- A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome.
- Authors: Benjamin JS, Pilarowski GO, Carosso GA, Zhang L, Huso DL, Goff LA, Vernon HJ, Hansen KD, Bjornsson HT
- Issue date: 2017 Jan 3